Ubs Group Ag Sutro Biopharma, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 165,859 shares of STRO stock, worth $442,843. This represents 0.0% of its overall portfolio holdings.

Number of Shares

165,859

Previous 31,352 429.02%

Holding current value

$442,843

Previous $91,000 529.67%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.88 - $5.01 $387,380 - $673,880	134,507 Added 429.02%	165,859 $573,000
Q2 2024 Aug 13, 2024	SELL	$2.92 - $5.33 $97,198 - $177,419	-33,287 Reduced 51.5%	31,352 $91,000
Q1 2024 May 13, 2024	BUY	$3.27 - $5.65 $16,506 - $28,521	5,048 Added 8.47%	64,639 $365,000
Q4 2023 Feb 09, 2024	BUY	$2.07 - $4.54 $48,889 - $107,225	23,618 Added 65.65%	59,591 $255,000
Q3 2023 Nov 09, 2023	BUY	$3.29 - $4.9 $19,440 - $28,954	5,909 Added 19.65%	35,973 $124,000
Q2 2023 Aug 11, 2023	SELL	$4.25 - $5.88 $223,703 - $309,499	-52,636 Reduced 63.65%	30,064 $139,000
Q1 2023 May 12, 2023	BUY	$4.48 - $8.45 $44,965 - $84,812	10,037 Added 13.81%	82,700 $382,000
Q4 2022 Feb 08, 2023	BUY	$5.41 - $8.08 $387,291 - $578,431	71,588 Added 6659.35%	72,663 $587,000
Q3 2022 Nov 10, 2022	SELL	$5.17 - $7.11 $13,690 - $18,827	-2,648 Reduced 71.13%	1,075 $6,000
Q2 2022 Aug 10, 2022	SELL	$3.41 - $8.95 $363,540 - $954,159	-106,610 Reduced 96.63%	3,723 $19,000
Q1 2022 May 16, 2022	BUY	$7.78 - $15.31 $858,390 - $1.69 Million	110,333 New	110,333 $907,000
Q4 2021 Feb 14, 2022	SELL	$14.25 - $23.53 $17,399 - $28,730	-1,221 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$16.88 - $22.38 $20,610 - $27,325	1,221 New	1,221 $23,000
Q2 2021 Aug 13, 2021	SELL	$18.03 - $23.82 $9,141 - $12,076	-507 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$20.29 - $27.54 $10,287 - $13,962	507 New	507 $12,000
Q4 2020 Feb 11, 2021	SELL	$10.16 - $23.98 $7,640 - $18,032	-752 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$7.44 - $13.15 $34,395 - $60,792	-4,623 Reduced 86.01%	752 $8,000
Q2 2020 Jul 31, 2020	SELL	$7.24 - $11.05 $9,071 - $13,845	-1,253 Reduced 18.9%	5,375 $42,000
Q1 2020 May 01, 2020	SELL	$6.19 - $12.16 $42,314 - $83,125	-6,836 Reduced 50.77%	6,628 $68,000
Q4 2019 Feb 14, 2020	BUY	$8.15 - $11.39 $38,908 - $54,375	4,774 Added 54.94%	13,464 $148,000
Q3 2019 Nov 14, 2019	BUY	$7.91 - $11.76 $53,155 - $79,027	6,720 Added 341.12%	8,690 $79,000
Q2 2019 Aug 14, 2019	BUY	$9.69 - $12.23 $19,089 - $24,093	1,970 New	1,970 $22,000
Q1 2019 May 14, 2019	SELL	$8.8 - $11.87 $33,070 - $44,607	-3,758 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$8.69 - $14.85 $21,811 - $37,273	2,510 Added 201.12%	3,758 $34,000
Q3 2018 Nov 14, 2018	BUY	$15.0 - $15.2 $18,720 - $18,969	1,248 New	1,248 $19,000

Others Institutions Holding STRO

# of Institutions

136

Shares Held

62.4M

Call Options Held

77.1K

Put Options Held

31.4K

View Full List

About SUTRO BIOPHARMA, INC.

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $139M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

More about STRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account